Ascendis Pharma Valuation
| A1SN34 Stock | BRL 56.10 0.00 0.00% |
At this time, the firm appears to be fairly valued. Ascendis Pharma AS shows a prevailing Real Value of R$56.0 per share. The current price of the firm is R$56.1. Our model approximates the value of Ascendis Pharma AS from analyzing the firm fundamentals such as return on equity of -0.67, and Operating Margin of (15.89) % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Ascendis Pharma's price fluctuation is very steady at this time. Calculation of the real value of Ascendis Pharma AS is based on 3 months time horizon. Increasing Ascendis Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Ascendis Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ascendis Stock. However, Ascendis Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 56.1 | Real 56.0 | Hype 56.1 | Naive 56.28 |
The real value of Ascendis Stock, also known as its intrinsic value, is the underlying worth of Ascendis Pharma AS Company, which is reflected in its stock price. It is based on Ascendis Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ascendis Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Ascendis Pharma AS helps investors to forecast how Ascendis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ascendis Pharma more accurately as focusing exclusively on Ascendis Pharma's fundamentals will not take into account other important factors: Ascendis Pharma Total Value Analysis
Ascendis Pharma AS is presently projected to have takeover price of 34.82 B with market capitalization of 34.39 B, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Ascendis Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
34.82 B | 34.39 B |
Ascendis Pharma Investor Information
The company has price-to-book (P/B) ratio of 0.9. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ascendis Pharma AS had not issued any dividends in recent years. Based on the key measurements obtained from Ascendis Pharma's financial statements, Ascendis Pharma AS is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Ascendis Pharma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Ascendis Pharma has an asset utilization ratio of 0.72 percent. This suggests that the Company is making R$0.007169 for each dollar of assets. An increasing asset utilization means that Ascendis Pharma AS is more efficient with each dollar of assets it utilizes for everyday operations.Ascendis Pharma Profitability Analysis
The company reported the revenue of 7.78 M. Net Loss for the year was (383.58 M) with profit before overhead, payroll, taxes, and interest of 4.25 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Ascendis Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Ascendis Pharma and how it compares across the competition.
About Ascendis Pharma Valuation
The stock valuation mechanism determines Ascendis Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of Ascendis Pharma. We calculate exposure to Ascendis Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ascendis Pharma's related companies.8 Steps to conduct Ascendis Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Ascendis Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Ascendis Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Ascendis Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Ascendis Pharma's revenue streams: Identify Ascendis Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Ascendis Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Ascendis Pharma's growth potential: Evaluate Ascendis Pharma's management, business model, and growth potential.
- Determine Ascendis Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Ascendis Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Ascendis Stock analysis
When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |